Intellia Therapeutics
NTLAIntellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Nova …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Intellia Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/4/2024 | Sell | Clark, Eliana | EVP, Chief Technical Officer | $33.0 | $19,959 |
| 3/4/2024 | Sell | Basta, James | EVP, General Counsel | $33.0 | $75,778 |
| 1/8/2024 | Sell | Sepp-Lorenzino, Laura | EVP, Chief Scientific Officer | $29.0 | $65,681 |
| 1/3/2024 | Sell | Clark, Eliana | EVP, Chief Technical Officer | $29.8 | $135,954 |
| 1/3/2024 | Sell | Basta, James | EVP, General Counsel | $29.5 | $112,095 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)